Similar articles

• RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.

  Daffu G, Shen X, Senatus L, Thiagarajan D, Abedini A, Hurtado Del Pozo C, Rosario R, Song F, Friedman RA, Ramasamy R, Schmidt AM. Daffu G, et al. Diabetes. 2015 Dec;64(12):4046-60. doi: 10.2337/db15-0575. Epub 2015 Aug 7. Diabetes. 2015. PMID: 26253613 Free PMC article.
• Recent progress in advanced glycation end products and diabetic complications.

  Vlassara H. Vlassara H. Diabetes. 1997 Sep;46 Suppl 2:S19-25. doi: 10.2337/diab.46.2.s19. Diabetes. 1997. PMID: 9285494 No abstract available.
• Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol.

  Xu L, Wang YR, Li PC, Feng B. Xu L, et al. Lipids Health Dis. 2016 Sep 19;15(1):161. doi: 10.1186/s12944-016-0334-0. Lipids Health Dis. 2016. PMID: 27644038 Free PMC article.
• Activation of the receptor for advanced glycation end products and consequences on health.

  Wautier MP, Guillausseau PJ, Wautier JL. Wautier MP, et al. Diabetes Metab Syndr. 2017 Oct-Dec;11(4):305-309. doi: 10.1016/j.dsx.2016.09.009. Epub 2016 Sep 4. Diabetes Metab Syndr. 2017. PMID: 27612394 Review.
• RAGE in diabetic nephropathy.

  Yamamoto H, Watanabe T, Yamamoto Y, Yonekura H, Munesue S, Harashima A, Ooe K, Hossain S, Saito H, Murakami N. Yamamoto H, et al. Curr Mol Med. 2007 Dec;7(8):752-7. doi: 10.2174/156652407783220769. Curr Mol Med. 2007. PMID: 18331233 Review.